M.D. (IMMUNOHAEMATOLOGY & BLOOD TRANSFUSION)

MAHARASHTRA UNIVERSITY OF HEALTH SCIENCES
In Nashik

Price on request
You can also call the Study Centre
25325... More
Compare this course with other similar courses
See all

Important information

  • Master
  • Nashik
  • Duration:
    3 Years
Description

Important information
Venues

Where and when

Starts Location
On request
Nashik
Vani Road, Mhasrul, Nashik , 422004, Maharashtra, India
See map

Course programme

M.D. (IMMUNOHAEMATOLOGY & BLOOD TRANSFUSION)

I. HISTORY OF TRANSFUSION MEDICINE
1.1. Scientific landmarks in its development
1.2. Impact of world wars on its development
1.3. Development of PVC bags
II. SCIENTIFIC BASIS OF TRANSFUSION
A. Biochemistry & Physiology of elements of blood
2.0 Process of cell production and life span
2.1 Red cells
2.2 White blood cells
2.3 Platelets
3.0 Red cells
3.1 Haemoglobin structure & function
3.2 Metabolic pathways
3.3 Membrane structure & function
4.0 White cells
4.1 Structure, function & kinetics
5.0 Platelets
5.1 Structure, function & kinetics
6.0 Physiology of Haemostasis
6.1 Role of platelets
6.2 Coagulation pathways
6.3 Fibrinolysis
7.0 Hemodynamics of blood flow & volume
8.0 Iron metabolism
9.0 Bilirubin metabolism
10. Immunology
10.0 Principles of Basic Immunology
10.1 Antigen, Antibody, Complement,
Immunoglobulin
10.2 Antigen/antibody reaction
10.3 Lymphocytes in Humoral &
Cellular immunity
11.0 Role of Hybridoma technology in
Immunology
12.0 Immunology of transplantation
13.0 HLA & genetic control of immune response
1. Genetics
14.0 Principles of basic genetics
15.0 Genetics of Blood groups
15.1 Phenotypes & genotypes
15.2 Principles of blood group inheritance
15.3 Population genetics of blood groups
III ANTIGEN SYSTEMS IN FORMED ELEMENTS OF BLOOD
16.0 Red cell antigens
17.0 Leucocyte antigens
18.0 Platelet antigens
IV BLOOD COLLECTION, PROCESSING,
COMPONENT PREPARATION
1. Management of blood donation
19.0 Donor recruitment
19.1. Voluntary blood donation system
19.2. Categories of blood donors
19.3. Education & awareness of prospective donors
20.0 Acceptability criteria of blood donor
21.0 Care of blood donors
21.1 Pre-donation
21.2 Mid-donation
21.3 Post-donation
21.4 Prevention & management of complications
of blood donation
22.0.Blood collection
22.1. Anticoagulants & preservatives
22.2.1 Procedure
22.2.2 Blood donation camps
2. Blood Components
23.0. Components
23.1 Types
23.2 Methods of preparation
23.3 Indications, dosage & administration
23.4 Leuco-depletion
23.4.1.Various Methods
23.4.2.Quality Control
24.0 Storage of blood & components
24.1. Whole blood
24.2. Red cell concentrate
24.3. Plasma
24.4. Granulocyte
24.5. Cryoprecipitate
24.6. Stem cells
24.6.1.Peripheral blood stem cells
24.6.2.Cord blood stem cells
25. 0 Plasma fractionation
V PRE-TRANSFUSION TESTING
26.0 Compatibility testing
26.1 ABO grouping & Rh typing
26.2. Antibody screening
26.3. Methods of cross matching
26.4. Newer methods of cross matching
26.4.1. Solid phase
26.4.2. Gel technology
27.0 Screening for Transfusion Transmitted Infections
27.1. Methodology
27.2 Nucleic acid amplification techniques
27.3 Newer emerging pathogens
27.3.1.1 Prions
27.3.1.2 C J disease
27.3.1.3 Lyme disease
27.3.1.4 Others
28.0 Selection of blood, components & plasma
products for transfusion
VI ADVERSE EFFECTS OF BLOOD TRANSFUSION
29.0 Clinical presentation, pathophysiology,
investigations, management
29.1. Hemolytic transfusion reaction
29.2. Non hemolytic transfusion Reaction
30.0. Transfusion Transmitted Infections
31.0. Transfusion Associated- Graft
versus Host Disease(TA-GVHD)
32.0. Transfusion Related Acute Lung Injury (TRALI)
33.0 Others
33.1. Haemosiderosis
33.2. Volume overload
VII APHERESIS
34.0. Technology of apheresis and various
machines
35.0 Haemapheresis (platelets, granulocytes, plasma)
35.1. Donor selection
35.2. Procedure
35.3. Complications
36.0 Therapeutic apheresis
36.1 Indications, procedure & Complications
36.2 Plasma exchange, red cell
Exchange
36.3 Newer methods of Immunoadsorption
VIII AUTOLOGOUS TRANSFUSION
37.0. Basic principles, indications, contra-indications
37.1. Pre-deposit
37.2. Haemodilution
37.3. Intra-operative blood salvage
including equipment
37.4. Directed donation
IX ANTENATAL & NEONATAL TRANSFUSION PRACTICE
38.0 Pathophysiology, diagnosis & management 1
38.1. Rh incompatibility
38.2. ABO & other blood group incompatibility
39.0 Exchange transfusion
39.1. Indications, methodology & complications
39.2. Intrauterine transfusion
40.0. Neonatal transfusion practice
X IMMUNOHEMATOLOGY
41.0 Classification, diagnosis and management
41.1 Immune haemolytic anaemia
41.2 Immune thrombocytopenia
41.3 Immune neutropenia
42.0. Immunohaematological problems in
multi-transfused patients
XI HEMOTHERAPY
43.0. Pathophysiology, diagnosis and management of
anaemia
43.1 Anaemia
43.2 Iron deficiency anaemia
43.3 Megaloblastic anaemia
43.4 Aplastic anaemia
43.5 Haemolytic anaemia including fragmentation syndrome
43.6 Anaemia of chronic diseases - liver disease, uremia, thyroid
disease
44.0. Haemoglobinopathies
44.1 Thalassaemia
44.2 Sickle cell anaemia
44.3 Other haemoglobinopathies
45.0. Pathophysiology, diagnosis and management of haemostatic disorders
45.1 Haemophilia
45.2 Von willebrands disease
45.3 Platelet disorders
45.4 Qualitative disorders
45.5 Quantitative disorders
45.6 DIC
46.0. Pathophysiology, diagnosis and transfusion
support in acute blood loss
46.1 Shock
46.2 Massive transfusion
47.0. Transfusion support in cardiac surgery
48.0 Classification & transfusion support in Oncology
48.1 Leukaemia
48.2 Lymphoma
48.3 Marrow failure
XII TRANSPLANTATION
46.0 Transfusion support in transplantation
48.1 Peripheral blood stem cell transplantation
46.1.1 Harvesting
46.1.2 Cryopreservation
46.1.3 CD34 counting
48.2 Bone marrow transplantation
48.2.1 Processing
48.2.2 Harvesting
48.2.3 Immunohaematological problems
in ABO mismatched BMT
48.3. Transfusion support in specialized conditions
48.3.1. Renal transplantation
48.3.2. Liver transplantation
48.3.3. Umbilical cord blood transplantation
48.3.3.1. Collection
48.3.3.2. Processing
48.3.3.3. HLA typing & cross matching
49.0 Irradiation of blood products
49.1. Indications, dosage, adverse effects 1
50.0 Tissue banking
XIII BLOOD SUBSTITUTE & HEMOOOIETIC AGENTS
51.0 Crystalloids & colloids
52.0 Oxygen carrying compounds
53.0 Haemopoietic growth factors
54.0 Albumin
55.0
XIV MEDICOLEGAL CONSIDERATIONS IN TRANSFUSION
55.0 Ethical & legal considerations pertaining
to transfusion practice
56.0 Identification of blood stains
57.0 Paternity testing
58.0 Donor notification and counselling
59.0 Look back programme
60.0 Drugs & Cosmetics act, Accreditation
XV TOTAL QUALITY MANAGEMENT
61.0 Development of Standard Operating
Procedures (SOP) manual
62.0 Quality control
62.1. Reagents
62.2. Instruments
62.3. Personnel
62.4. Blood & Components
63.0 Quality assurance
63.1. Internal quality control
63.2. External quality control
64.0 Medical audit
65.0 Hospital transfusion committee
66.0 Good manufacturing practice (GMP)
67.0 Turnaround time
68.0 ISO 9000
XVI ORGANISATION & MANAGEMENT OF
TRANSFUSION SERVICES
69.0 Organisation & function of blood
services & hospital transfusion practice
69.1. Donor recruitment & motivation
69.2 Operation of blood mobile units
69.3 Development of transfusion services
69.4 Inventory control
69.5 Development of forms, labels, records etc.
69.6 Reports & Returns
70.0 National Blood Transfusion Policy
XVII BLOOD SAFETY
71.0 Sterilization
72.0 Disposal of bio-hazardous material
XVIII MODERN BIOLOGICAL TECHNIQUES
73.0 Principles, methods, relevance in transfusion medicine
73.1 Western blot
73.2 Polymerase chain reaction
73.2.1 SSCP
73.2.2 SSOP
73.3 Dot blot hybridization
XIX AUTOMATION & COMPUTERIZATION
74.0 Automated blood grouping & processing
75.0 Instrumentation & use of bar codes
76.0 Use of computers in blood banking including Implementation of
blood banking software


Compare this course with other similar courses
See all